IPHA

IPHA

USD

Innate Pharma S.A. ADS

$1.840-0.040 (-2.128%)

Preço em tempo real

Healthcare
Biotecnologia
França

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$1.880

Máximo

$1.880

Mínimo

$1.840

Volume

0.00M

Fundamentos da empresa

Capitalização de mercado

172.7M

Setor

Biotecnologia

País

France

Estatísticas de negociação

Volume médio

0.02M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $1.29Atual $1.840Máximo $3.511

Notícias relacionadas

BusinessWire

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an

Ver mais
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Analyst Upgrades

HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Innate Pharma from Neutral to Buy and announces $5 price target.

Ver mais
HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target

BTIG analyst Justin Zelin reiterates Innate Pharma with a Buy and maintains $8 price target.

Ver mais
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.